Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7391 p286
11 March 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Scottish methadone service to be reviewed

Methadone

Unsupervised methadone consumption has raised child protection issues

Scotland's methadone service is to be reviewed following the death at the end of last year of a toddler who drank methadone mixture.

Scottish Executive First Minister Jack McConnell asked the Scottish ministers for justice, education and health to report on current drug rehabilitation policies at a Cabinet meeting on Wednesday, as The Journal went to press. The meeting decided to order officials to look closely at the operation of the methadone programme.

Mr McConnell said: “I am not yet convinced that our policy on rehabilitation is clear enough or that the implementation and service provision across Scotland is consistent enough. I want us to review the position in relation to the prescription of methadone … taken unsupervised. I also want us to be clear that, when people are on methadone programmes or managed medication programmes, those programmes are directed towards an end result.”

Following the Cabinet meeting, a spokesman said: “The ministers for health and justice agreed that their officials would jointly review current guidelines and good practice in relation to methadone prescribing and administration.” He added that the ministers noted that current guidelines took little account of child protection issues.

Stuart Notman, an Aberdeen community pharmacist who supplies methadone to 140 patients, believes that politicians need to adopt a holistic approach to treating addiction, minimising harm and preventing crime.

He said: “This should be more about crime prevention and harm minimisation than treatment. There are a host of social and environmental problems that go hand in hand. It’s difficult to get someone off drugs if that’s all the help they’re being offered.”

Back to Top


©The Pharmaceutical Journal